Doughnuts and discounts — Changes to Medicare Part D under the Bipartisan Budget Act of 2018

New England Journal of Medicine

24 May 2018 - The Medicare Prescription Drug Improvement and Modernization Act of 2003 created a new Medicare benefit (Part D), a new insurance product (prescription-drug–only plans), and a new market. 

Fifteen years later, Part D is widely regarded as a success, providing drug coverage to 42.5 million Medicare beneficiaries and substantially reducing out-of-pocket drug expenditures among enrollees. 

Many of the statutory and regulatory provisions governing Part D have remained unchanged since its inception, including its reliance on private plans to negotiate drug prices with manufacturers instead of allowing direct negotiation by the government.

Read New England Journal of Medicine perspective

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Medicare